loading
Inspire Medical Systems Inc stock is traded at $59.76, with a volume of 1.89M. It is up +0.18% in the last 24 hours and down -35.37% over the past month. Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
See More
Previous Close:
$59.65
Open:
$59.64
24h Volume:
1.89M
Relative Volume:
1.18
Market Cap:
$1.71B
Revenue:
$861.31M
Net Income/Loss:
$53.12M
P/E Ratio:
34.62
EPS:
1.7262
Net Cash Flow:
$85.01M
1W Performance:
-9.04%
1M Performance:
-35.37%
6M Performance:
-31.59%
1Y Performance:
-68.07%
1-Day Range:
Value
$59.64
$63.50
1-Week Range:
Value
$53.11
$71.16
52-Week Range:
Value
$53.11
$197.75

Inspire Medical Systems Inc Stock (INSP) Company Profile

Name
Name
Inspire Medical Systems Inc
Name
Phone
763-957-5037
Name
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Name
Employee
1,246
Name
Twitter
@inspiresleep
Name
Next Earnings Date
2025-02-10
Name
Latest SEC Filings
Name
INSP's Discussions on Twitter

Compare INSP vs ABT, SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
INSP
Inspire Medical Systems Inc
59.76 1.70B 861.31M 53.12M 85.01M 1.7262
Medical Devices icon
ABT
Abbott Laboratories
112.68 193.83B 44.33B 6.48B 6.92B 3.7033
Medical Devices icon
SYK
Stryker Corp
366.05 140.01B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
99.49 129.33B 34.76B 4.79B 5.21B 3.7017
Medical Devices icon
BSX
Boston Scientific Corp
74.73 109.92B 20.08B 2.89B 3.82B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
75.87 44.36B 6.07B 1.06B 799.60M 1.8527

Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-12-26 Downgrade Robert W. Baird Outperform → Neutral
Feb-12-26 Downgrade Wells Fargo Overweight → Equal Weight
Jan-27-26 Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-22-26 Downgrade Oppenheimer Outperform → Perform
Jan-22-26 Downgrade Truist Buy → Hold
Dec-08-25 Upgrade Oppenheimer Perform → Outperform
Dec-02-25 Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-26-25 Upgrade Truist Hold → Buy
Nov-25-25 Upgrade Wolfe Research Peer Perform → Outperform
Nov-24-25 Upgrade Stifel Hold → Buy
Nov-04-25 Upgrade Wells Fargo Equal Weight → Overweight
Oct-24-25 Downgrade Jefferies Buy → Hold
Sep-22-25 Downgrade UBS Buy → Neutral
Sep-02-25 Initiated Evercore ISI Outperform
Aug-05-25 Downgrade JP Morgan Overweight → Neutral
Aug-05-25 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Aug-05-25 Downgrade Truist Buy → Hold
Nov-20-24 Upgrade BofA Securities Neutral → Buy
May-08-24 Downgrade BofA Securities Buy → Neutral
Apr-19-24 Initiated RBC Capital Mkts Outperform
Mar-19-24 Initiated Morgan Stanley Overweight
Feb-06-24 Resumed KeyBanc Capital Markets Overweight
Jan-19-24 Initiated Jefferies Buy
Jan-02-24 Downgrade Stifel Buy → Hold
Dec-13-23 Downgrade Wells Fargo Overweight → Equal Weight
Jul-19-23 Initiated Robert W. Baird Outperform
Apr-14-23 Initiated Mizuho Buy
Mar-29-23 Initiated UBS Buy
Dec-13-22 Upgrade Goldman Neutral → Buy
Dec-13-22 Initiated KeyBanc Capital Markets Overweight
Apr-13-22 Initiated Truist Buy
Apr-06-22 Initiated Wolfe Research Peer Perform
Mar-02-22 Resumed BofA Securities Buy
Jan-04-21 Downgrade BofA Securities Buy → Neutral
Dec-15-20 Downgrade Goldman Buy → Neutral
Nov-03-20 Upgrade BofA Securities Neutral → Buy
Nov-03-20 Upgrade Oppenheimer Underperform → Perform
Sep-22-20 Initiated JP Morgan Overweight
Sep-02-20 Initiated Robert W. Baird Outperform
Aug-06-20 Downgrade BofA Securities Buy → Neutral
Jul-15-20 Initiated Goldman Buy
Jun-18-20 Reiterated Piper Sandler Overweight
May-18-20 Initiated Lake Street Buy
Apr-28-20 Upgrade BofA/Merrill Neutral → Buy
Apr-09-20 Initiated Piper Sandler Overweight
Jan-28-20 Initiated Oppenheimer Underperform
Jan-27-20 Initiated Oppenheimer Underperform
Nov-06-19 Upgrade Berenberg Sell → Hold
Feb-05-19 Initiated Dougherty & Company Buy
Nov-28-18 Initiated Berenberg Sell
Oct-29-18 Initiated Leerink Partners Outperform
May-29-18 Initiated Guggenheim Buy
May-29-18 Initiated Stifel Buy
May-29-18 Initiated Wells Fargo Outperform
View All

Inspire Medical Systems Inc Stock (INSP) Latest News

pulisher
07:07 AM

Inspire Medical Systems Inc. (INSP) Confronts Near-Term Headwinds Despite Profitability - Insider Monkey

07:07 AM
pulisher
Feb 14, 2026

10 Best Medical Technology Stocks to Invest In - Insider Monkey

Feb 14, 2026
pulisher
Feb 14, 2026

Is Inspire Medical Systems Inc. stock dividend yield sustainableTrade Analysis Summary & Community Verified Trade Signals - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Why is Inspire Medical Systems Inc. stock going downRate Hike & Community Trade Idea Sharing Platform - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Can Inspire Medical Systems Inc. (2DR) stock retain market dominanceJuly 2025 Gainers & Stock Timing and Entry Methods - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Despite Q4 beats, Inspire Medical declines on revised 2026 revenue outlook - MSN

Feb 14, 2026
pulisher
Feb 14, 2026

Technical Reactions to INSP Trends in Macro Strategies - Stock Traders Daily

Feb 14, 2026
pulisher
Feb 14, 2026

Inspire Medical Systems, Inc. Just Beat EPS By 401%: Here's What Analysts Think Will Happen Next - Yahoo Finance

Feb 14, 2026
pulisher
Feb 14, 2026

Results: Inspire Medical Systems, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st

Feb 14, 2026
pulisher
Feb 14, 2026

Thrivent Financial for Lutherans Has $1.44 Million Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat

Feb 14, 2026
pulisher
Feb 14, 2026

Decoding Inspire Medical Systems Inc (INSP): A Strategic SWOT In - GuruFocus

Feb 14, 2026
pulisher
Feb 13, 2026

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc.INSP - PR Newswire

Feb 13, 2026
pulisher
Feb 13, 2026

Inspire Medical Systems, Inc. SEC 10-K Report - TradingView

Feb 13, 2026
pulisher
Feb 13, 2026

INSP Downgraded to Peer Perform by Wolfe Research | INSP Stock N - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Atricure (ATRC) and Inspire Medical Systems (INSP) - The Globe and Mail

Feb 13, 2026
pulisher
Feb 13, 2026

6.4 Million Medicare Recipients Face New Hurdles in Getting Care - AOL.com

Feb 13, 2026
pulisher
Feb 13, 2026

Inspire Medical Systems (NYSE:INSP) Downgraded to Hold Rating by Robert W. Baird - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

Inspire Medical Systems (NYSE:INSP) Lowered to "Hold" Rating by Wells Fargo & Company - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

Wolfe Research downgrades Inspire Medical Systems stock rating to Peerperform - Investing.com Canada

Feb 13, 2026
pulisher
Feb 13, 2026

Inspire Medical Systems stock hits 52-week low at $56.17 By Investing.com - Investing.com Canada

Feb 13, 2026
pulisher
Feb 13, 2026

Piper Sandler lowers Inspire Medical Systems stock price target on reimbursement concerns - Investing.com Nigeria

Feb 13, 2026
pulisher
Feb 12, 2026

Baird downgrades Inspire Medical stock to Neutral on reimbursement concerns - Investing.com Nigeria

Feb 12, 2026
pulisher
Feb 12, 2026

What the FDA’s 2026 Update Means for Wearables - AOL.com

Feb 12, 2026
pulisher
Feb 12, 2026

Jefferies Lowers Price Target for INSP, Keeps Hold Rating | INSP Stock News - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical Systems (NYSE:INSP) Price Target Cut to $66.00 by Analysts at Jefferies Financial Group - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Analyst Shagun Singh Maintains Rating for Inspire Medical Systems (INSP) | INSP Stock News - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Stifel lowers Inspire Medical Systems stock price target on reimbursement issues - Investing.com Canada

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical: Still A Long Way From A Good Night’s Sleep (NYSE:INSP) - Seeking Alpha

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Finviz

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical Systems Lowers FY2026 Revenue Guidance After CMS Coding Clarification, Oppenheimer Says - marketscreener.com

Feb 12, 2026
pulisher
Feb 12, 2026

INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical Systems (NYSE:INSP) Shares Gap Down on Analyst Downgrade - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Piper Sandler Lowers Price Target for INSP to $85, Maintains Ove - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Wells Fargo Downgrades INSP to Equal-Weight, Lowers Price Target - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

INSP: Mizuho Lowers Price Target to $85, Maintains Outperform Ra - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical Systems stock hits 52-week low at $56.17 - Investing.com

Feb 12, 2026
pulisher
Feb 12, 2026

INSP Q4 Deep Dive: Reimbursement Uncertainty Shapes Outlook Despite Strong Product Adoption - Finviz

Feb 12, 2026
pulisher
Feb 12, 2026

This Inspire Medical Systems Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga

Feb 12, 2026
pulisher
Feb 12, 2026

Truist Cuts Price Target on Inspire Medical Systems to $70 From $96, Keeps Hold Rating - marketscreener.com

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical Systems (NYSE:INSP) Price Target Cut to $70.00 by Analysts at Truist Financial - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical Systems (NYSE:INSP) Given New $85.00 Price Target at Piper Sandler - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Mizuho Has Lowered Expectations for Inspire Medical Systems (NYSE:INSP) Stock Price - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2025 earnings call transcript - MSN

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 12, 2026
pulisher
Feb 12, 2026

RBC Cuts Price Target on Inspire Medical Systems to $68 From $90, Keeps Sector Perform Rating - marketscreener.com

Feb 12, 2026
pulisher
Feb 12, 2026

Baird Downgrades Inspire Medical Systems to Neutral From Outperform, Adjusts Price Target to $74 From $130 - marketscreener.com

Feb 12, 2026
pulisher
Feb 12, 2026

Piper Sandler lowers Inspire Medical Systems stock price target on reimbursement concerns By Investing.com - Investing.com India

Feb 12, 2026
pulisher
Feb 12, 2026

What 19 Analyst Ratings Have To Say About Inspire Medical Systems - Benzinga

Feb 12, 2026
pulisher
Feb 12, 2026

Inspire Medical Stock Pre-Market (-8.7%) : Weak 2026 Revenue Guidance - Trefis

Feb 12, 2026
pulisher
Feb 12, 2026

Baird Downgrades Inspire Medical Systems (INSP) and Lowers Price Target | INSP Stock News - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Wells Fargo downgrades Inspire Medical Systems stock rating on reimbursement concerns - Investing.com India

Feb 12, 2026

Inspire Medical Systems Inc Stock (INSP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices ZBH
$96.45
price up icon 1.33%
medical_devices STE
$248.35
price up icon 1.69%
$70.02
price up icon 7.59%
medical_devices PHG
$31.25
price down icon 0.51%
$80.34
price up icon 2.15%
medical_devices EW
$75.87
price down icon 0.75%
Cap:     |  Volume (24h):